<VariationArchive VariationID="10159" VariationName="NM_000132.4(F8):c.209_212del (p.Leu69_Phe70insTer)" VariationType="Deletion" Accession="VCV000010159" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-17" DateCreated="2013-04-04" MostRecentSubmission="2023-10-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25198" VariationID="10159">
      <GeneList>
        <Gene Symbol="F8" FullName="coagulation factor VIII" GeneID="2157" HGNC_ID="HGNC:3546" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154835792" stop="155022723" display_start="154835792" display_stop="155022723" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154064062" stop="154250997" display_start="154064062" display_stop="154250997" Strand="-" />
          </Location>
          <OMIM>300841</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000132.4(F8):c.209_212del (p.Leu69_Phe70insTer)</Name>
      <CanonicalSPDI>NC_000023.11:154999531:ACAAACA:ACA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154999532" stop="154999535" display_start="154999532" display_stop="154999535" variantLength="4" positionVCF="154999531" referenceAlleleVCF="TACAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154227807" stop="154227810" display_start="154227807" display_stop="154227810" variantLength="4" positionVCF="154227806" referenceAlleleVCF="TACAA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>F8, 4-BP DEL, FS</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.154227810_154227813del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.154227810_154227813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154999535_154999538del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154999535_154999538del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011403.2" sequenceAccession="NG_011403" sequenceVersion="2" change="g.28189_28192del">
            <Expression>NG_011403.2:g.28189_28192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000132.4" sequenceAccession="NM_000132" sequenceVersion="4" change="c.209_212del" MANESelect="true">
            <Expression>NM_000132.4:c.209_212del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000123.1" sequenceAccession="NP_000123" sequenceVersion="1" change="p.Leu69_Phe70insTer">
            <Expression>NP_000123.1:p.Leu69_Phe70insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_555" sequenceAccession="LRG_555">
            <Expression>LRG_555:g.28189_28192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_555t1" sequenceAccession="LRG_555t1">
            <Expression>LRG_555t1:c.209_212del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_555p1" sequenceAccession="LRG_555p1" change="p.Leu69_Phe70insTer">
            <Expression>LRG_555p1:p.Leu69_Phe70insTer</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA255050" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300841.0076" DB="OMIM" />
        <XRef Type="rs" ID="387906434" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000132.4(F8):c.209_212del (p.Leu69_Phe70insTer) AND Hereditary factor VIII deficiency disease" Accession="RCV000010872" Version="15">
        <ClassifiedConditionList TraitSetID="2866">
          <ClassifiedCondition DB="MedGen" ID="C0019069">Hereditary factor VIII deficiency disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-05-05" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-05" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2023-10-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7728145</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2866" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2126" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hemophilia A, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEM A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor 8 deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Factor VIII deficiency, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOSOMAL HEMOPHILIA A</ElementValue>
                <XRef Type="MIM" ID="134500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemophilia A</ElementValue>
                <XRef ID="MONDO:0010602" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary factor VIII deficiency disease</ElementValue>
                <XRef ID="Hereditary+factor+VIII+deficiency+disease/8517" DB="Genetic Alliance" />
                <XRef ID="28293008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HEMA</ElementValue>
                <XRef Type="MIM" ID="306700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6591" />
                <XRef ID="6591" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hemophilia A is characterized by deficiency in factor VIII clotting activity that results in prolonged oozing after injuries, tooth extractions, or surgery, and delayed or recurrent bleeding prior to complete wound healing. The age of diagnosis and frequency of bleeding episodes are related to the level of factor VIII clotting activity. Individuals with severe hemophilia A are usually diagnosed during the first two years of life following oral or soft tissue bleeding either with procedures or due to a known family history of hemophilia. Without prophylactic treatment, individuals may average up to two to five spontaneous bleeding episodes each month including spontaneous joint bleeds or deep-muscle hematomas, and prolonged bleeding or excessive pain and swelling from minor injuries, surgery, and tooth extractions. Individuals with moderate hemophilia A seldom have spontaneous bleeding, although it varies between individuals; however, they do have prolonged or delayed bleeding after relatively minor trauma and are usually diagnosed before age five to six years; the frequency of bleeding episodes varies, usually from once a month to once a year. Individuals with mild hemophilia A do not have spontaneous bleeding episodes; however, without pre- and postoperative treatment, abnormal bleeding occurs with surgery or tooth extractions; the frequency of bleeding episodes varies widely, typically from once a year to once every ten years. Individuals with mild hemophilia A are often not diagnosed until later in life. Approximately 30% of heterozygous females have factor VIII clotting activity below 40% and are at risk for bleeding (even if males in the family are only mildly affected). After major trauma or invasive procedures, prolonged or excessive bleeding usually occurs, regardless of severity. In addition, 25% of heterozygous females with normal factor VIII clotting activity report an increased bleeding tendency.</Attribute>
                <XRef ID="NBK1404" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301578</ID>
                <ID Source="BookShelf">NBK1404</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21654722</ID>
              </Citation>
              <Citation Type="general" Abbrev="UKHCDO, 2013">
                <ID Source="PubMed">23157203</ID>
              </Citation>
              <XRef ID="98878" DB="Orphanet" />
              <XRef ID="C0019069" DB="MedGen" />
              <XRef ID="MONDO:0010602" DB="MONDO" />
              <XRef Type="MIM" ID="134500" DB="OMIM" />
              <XRef Type="MIM" ID="306700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31099" SubmissionDate="2012-09-14" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300841.0076_HEMOPHILIA A" title="F8, 4-BP DEL, FS_HEMOPHILIA A" />
        <ClinVarAccession Accession="SCV000031099" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Antonarakis et al. (1995) reported in a patient with severe hemophilia A (306700) the deletion of 4 nucleotides (GTTT) resulting in a frameshift downstream from codon 50 in exon 2.</Attribute>
              <Citation>
                <ID Source="PubMed">7728145</ID>
              </Citation>
              <XRef DB="OMIM" ID="306700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <Name>F8, 4-BP DEL, FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300841.0076" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOPHILIA A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2899481" SubmissionDate="2022-01-04" DateLastUpdated="2022-01-08" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="194062|OMIM:306700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001471660" DateUpdated="2022-01-08" DateCreated="2021-01-26" Type="SCV" Version="2" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The F8 c.209_212delTTGT; p.Phe70Ter variant (rs387906434), also known as c.208_211delTTTG, is published in the medical literature in numerous individuals with severe hemophilia A (Becker 1996, Habart 2003, Liu 1998, F8 database and references therein). Samples from affected individuals with this variant typically exhibit less than 1% of wildtype clotting activity (Habart 2003, Liu 1998, F8 database and references therein). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes 4 nucleotides, leads to an immediate stop codon and is predicted to result in a truncated protein or mRNA subject to non-sense mediated decay. Considering available information, this variant is considered to be pathogenic. References: Link to F8 database: http://www.factorviii-db.org Becker J et al. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet. 1996 Apr;58(4):657-70.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.154227810_154227813delAACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2020 ARUP</SubmissionName>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7574164" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20300119348" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047428" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The F8 c.209_212del (p.Phe70Ter) variant has been reported in hemizygous state in individuals affected with Hemophilia A (Habart 2003). This variant has been reported to the ClinVar database as Pathogenic. The p.Phe70Ter variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001928" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003125" />
              </Trait>
              <Comment>Clinical Suspicion: Hemophilia A Investigations: F8 levels (&lt;1%); Intron 22 inversion - Negative</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000132.4:c.209_212del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5002524" SubmissionDate="2022-12-11" DateLastUpdated="2022-12-17" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="sa_pathology/familial_cancer_frome_rd/vc15586" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002556570" DateUpdated="2022-12-17" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6233</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000132.3:c.209_212delTTGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="306700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_33</SubmissionName>
          <SubmissionName>submission_36</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2899481" TraitType="Disease" MappingType="XRef" MappingValue="306700" MappingRef="OMIM">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574164" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001928" MappingRef="HP">
        <MedGen CUI="C1846821" Name="Abnormality of coagulation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5002524" TraitType="Disease" MappingType="XRef" MappingValue="306700" MappingRef="OMIM">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574164" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003125" MappingRef="HP">
        <MedGen CUI="C4025649" Name="Reduced factor VIII activity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574164" TraitType="Disease" MappingType="XRef" MappingValue="306700" MappingRef="OMIM">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31099" TraitType="Disease" MappingType="Name" MappingValue="HEMOPHILIA A" MappingRef="Preferred">
        <MedGen CUI="C0019069" Name="Hereditary factor VIII deficiency disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

